“Current rules and regulations make it hard for researchers to study how marijuana and marijuana-derived medications can best be used to treat various conditions,” Feinstein said in a press release. “This important legislation will cut the red-tape around the research process, helping get FDA-approved, marijuana-derived medications safely to patients.”
Seems like it’s all heating up in the US for a reason, can’t help but think this bill (which was passed only a few days ago!) should have some impact on the FDA approval process and speed up EMDs *inevitable * progress!
Its my understating that the US House is voting on legalising cannabis on a federal level this week, which may also be spurring ‘pot stocks’ on. Not sure it will be passed as last time it was shot down, don’t see how that will have much of an impact on EMD aside from general eyes on the market
Bring on the week!!
EMD Price at posting:
36.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)